1-Methyl-5-(trifluoromethyl)-1H-benzimidazol-2-amine hydrobromide, 95.0%, 250mg

Symbole d'avertissement selon ISO 7010 Étiquette individuelle, Risque biologique, Longueur de côté 200 mm, 1 pièce

(S)-((1R,2S,5R)-2-isopropyl-5-methylcyclohexyl) 4-methylbenzenesulfinate, 98%, 1g

2-(Benzo[b]thiophen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane>98.0%(GC)(T)1g

2,6-Difluoroaniline, 97.0%, 500g

4-Fluoro-3-isopropoxybenzaldehyde, 95.0%, 1g

4-Isopropoxy-2,6-dimethylbenzoic acid, 95+%, 2g

2,6-Dichloro-N-methoxy-N-methylisonicotinamide, 95.0%, 1g

(S)-2-((ethoxycarbonyl)amino)-3,3-dimethylbutanoic acid, 97%, 250mg

3-Bromoquinolin-5-amine, 95.0%, 5g

Ethyl (E)-3-(6-amino-3-chloro-2-fluorophenyl)acrylate, 98%, 1g

2,3,4-Trifluorophenylacetic acid, 97.0%, 250mg

(3,3-dimethylcyclobutyl)methanamine hydrochloride, 95.0%, 250mg